Citations

Showing 10 of 108094 citations.

Vascular Implications of COVID-19: Role of Radiological Imaging, Artificial Intelligence, and Tissue Characterization: A Special Report
Khanna, Narendra N. , Maindarkar, Mahesh , Paul, Sudip , Bhagawati, Mrinalini , Ahluwalia, Puneet , Ruzsa, Zoltán , Munjral, Smiksha , Krishnan, Padukone R., Singh, Inder M. , Laird, John R. , Fatemi, Mostafa , Dhanjil, Surinder, Saba, Luca , Balestrieri, Antonella , Faa, Gavino , Paraskevas, Kosmas I. , Misra, Durga Prasanna , Agarwal, Vikas , Sharma, Aman , Teji, Jagjit S. , Al-Maini, Mustafa , Rathore, Vijay , Naidu, Subbaram, Liblik, Kiera , Johri, Amer M. , Turk, Monika, Sobel, David , Pareek, Gyan , Miner, Martin , Višković, Klaudija , Tsoulfas, George, Protogerou, Athanase D. , Mavrogeni, Sophie , Fouda, Mostafa M. , Kalra, Manudeep, Suri, Jasjit S. , Paul, Sudip , Bhagawati, Mrinalini , Ruzsa, Zoltan , Munjral, Smiksha , Fatemi, Mostafa , Faa, Gavino , Paraskevas, Kosmas I , Agarwal, Vikas , Tsoulfas, George , Protogerou, Athanasios , Mavrogeni, Sophie , Fouda, Mostafa M , Misra, Durga Prasanna , Naidu, Subbaram , Maindarkar, Mahesh A , Puvvula, Anudeep , Sharma, Aditya , Kolluri, Raghu , Alizad, Azra , Nicolaides, Andrew , Kitas, George D. , Suri, Jasjit S.

Mayo Clinic

Journal of Cardiovascular Development and Disease | August 15, 2022 | Volume: 9 | Issue: 8 | Pages: 268

10.3390/jcdd9080268 | PMID 36005433 Get It

The SARS-CoV-2 virus has caused a pandemic, infecting nearly 80 million people worldwide, with mortality exceeding six million. The average survival span is just 14 days from the time the symptoms become aggressive. The present study delineates the deep-driven vascular damage in the pulmonary, renal, coronary, and carotid vessels due to SARS-CoV-2. This special report addresses an important gap in the literature in understanding (i) the pathophysiology of vascular damage and the role of medical imaging in the visualization of the damage caused by SARS-CoV-2, and (ii) further understanding the severity of COVID-19 using artificial intelligence (AI)-based tissue characterization (TC). PRISMA was used to select 296 studies for AI-based TC. Radiological imaging techniques such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound were selected for imaging of the vasculature infected by COVID-19. Four kinds of hypotheses are presented for showing the vascular damage in radiological images due to COVID-19. Three kinds of AI models, namely, machine learning, deep learning, and transfer learning, are used for TC. Further, the study presents recommendations for improving AI-based architectures for vascular studies. We conclude that the process of vascular damage due to COVID-19 has similarities across vessel types, even though it results in multi-organ dysfunction. Although the mortality rate is ~2% of those infected, the long-term effect of COVID-19 needs monitoring to avoid deaths. AI seems to be penetrating the health care industry at warp speed, and we expect to see an emerging role in patient care, reduce the mortality and morbidity rate.
Fulminant Influenza A Myocarditis Complicated by Transient Ventricular Wall Thickening and Cardiac Tamponade
Radovanovic, Milan , Dumic, Igor , Nordstrom, Charles W. , Hanna, Richard D. , Dumic, Igor

Mayo Clinic

Infectious Disease Reports | August 15, 2022 | Volume: 14 | Issue: 4 | Pages: 600-608

10.3390/idr14040065 | PMID 36005267 Get It

Myocarditis is an infrequent complication of influenza infection that is most often diagnosed clinically in the setting of confirmed influenza infection and elevated cardiac enzymes. Pericarditis can also occur in cases of influenza myocarditis and may require pericardiocentesis for tamponade. Patients with fulminant myocarditis have cardiogenic shock; however, echocardiographic findings may be subtle, showing a preserved ejection fraction and diffuse left ventricular wall thickening (compared to baseline) due to inflammatory edema. Recognizing these echocardiographic findings in the appropriate clinical setting facilitates the early recognition of fulminant myocarditis. Therefore, we report a case of fulminant influenza A myocarditis in healthy 37-year-old women complicated by transient left ventricular wall thickening and tamponade, highlighting the importance of early diagnosis and supportive management for a successful outcome.
Progression and survival of MBL: a screening study of 10 139 individuals
Slager, Susan L. , Parikh, Sameer A. , Achenbach, Sara J., Rabe, Kari G. , Boddicker, Nicholas , Kleinstern, Geffen , Lesnick, Connie , Call, Timothy G. , Vachon, Celine M. , Braggio, Esteban , Hanson, Curtis A. , Shanafelt, Tait D. , Chaffee, Kari G. , Boddicker, Nicholas J , Lesnick, Connie E, Cerhan, James R , Vachon, Celine M. , Kay, Neil E , Braggio, Esteban , Parikh, Sameer A , Shanafelt, Tait D , Slager, Susan L , Norman, Aaron D. , Olson, Janet E. , Cerhan, James R. , Kay, Neil E.

Mayo Clinic

Blood | August 15, 2022 | Volume: 140 | Issue: 15 | Pages: 1702-1709

10.1182/blood.2022016279 | PMID 35969843 Get It

Abstract Monoclonal B-cell lymphocytosis (MBL) is a common hematological premalignant condition that is understudied in screening cohorts. MBL can be classified into low-count (LC) and high-count (HC) types based on the size of the B-cell clone. Using the Mayo Clinic Biobank, we screened for MBL and evaluated its association with future hematologic malignancy and overall survival (OS). We had a two-stage study design including discovery and validation cohorts. We screened for MBL using an eight-color flow-cytometry assay. Medical records were abstracted for hematological cancers and death. We used Cox regression to evaluate associations and estimate hazard ratios and 95% confidence intervals (CIs), adjusting for age and sex. We identified 1712 (17%) individuals with MBL (95% LC-MBL), and the median follow-up time for OS was 34.4 months with 621 individuals who died. We did not observe an association with OS among individuals with LC-MBL (P = .78) but did among HC-MBL (hazard ratio, 1.8; 95% CI, 1.1-3.1; P = .03). Among the discovery cohort with a median of 10.0 years follow-up, 31 individuals developed hematological cancers with two-thirds being lymphoid malignancies. MBL was associated with 3.6-fold risk of hematological cancer compared to controls (95% CI, 1.7-7.7; P < .001) and 7.7-fold increased risk for lymphoid malignancies (95% CI:3.1-19.2; P < .001). LC-MBL was associated with 4.3-fold risk of lymphoid malignancies (95% CI, 1.4-12.7; P = .009); HC-MBL had a 74-fold increased risk (95% CI, 22-246; P < .001). In this large screening cohort, we observed similar survival among individuals with and without LC-MBL, yet individuals with LC-MBL have a fourfold increased risk of lymphoid malignancies. Accumulating evidence indicates that there are clinical consequences to LC-MBL, a condition that affects 8 to 10 million adults in the United States.
Simulation Optimization Gantry Call-Back Control Method for Proton Therapy Systems
Wang, Feifan , Huang, Yu-Li , Ju, Feng , Wang, Feifan

Mayo Clinic

IEEE Transactions on Automation Science and Engineering | August 15, 2022 | Volume: 20 | Issue: 3 | Pages: 1565-1576

10.1109/tase.2022.3198106 Get It

Implementation Strategy for Highly-Coordinated Cochlear Implant Care With Remote Programming: The Complete Cochlear Implant Care Model
Nassiri, Ashley M. , Saoji, Aniket A. , DeJong, Melissa D., Tombers, Nicole M. , Driscoll, Colin L. W., Neff, Brian A., Haynes, David S. , Carlson, Matthew L.

Mayo Clinic

Otology & Neurotology | August 15, 2022 | Volume: 43 | Issue: 8 | Pages: e916-e923

10.1097/mao.0000000000003644 | PMID 35970171 Get It

Objective To introduce and discuss implementation strategy for the Complete Cochlear Implant Care (CCIC) model, a highly-coordinated cochlear implant (CI) care delivery model requiring a single on-site visit for preoperative workup, surgery, and postoperative programming. Study Design Prospective, nonrandomized, two-arm clinical trial. Setting Tertiary referral CI center. Patients Adults who meet audiologic criteria for cochlear implantation. Interventions Cochlear implantation, coordinated care delivery, including remote programming. Main outcome measures Care delivery model feasibility and process implementation. Results Patients determined to be likely CI candidates based on routine audiometry are eligible for enrollment. The CCIC model uses telemedicine and electronic educational materials to prepare patients for same-day on-site consultation with CI surgery, same or next-day activation, and postoperative remote programming for 12 months. Implementation challenges include overcoming inertia related to the implementation of a new clinical workflow, whereas scalability of the CCIC model is limited by current hardware requirements for remote programming technology. A dedicated CCIC process coordinator is critical for overcoming obstacles in implementation and process improvement through feedback and iterative changes. Team and patient-facing materials are included and should be tailored to fit each unique CI program looking to implement CCIC. Conclusion The CCIC model has the potential to dramatically streamline hearing healthcare delivery. Implementation requires an adaptive approach, as obstacles may vary according to institutional infrastructure and policies.
Prominent Mitochondrial Injury as an Early Event in Heme Protein-Induced Acute Kidney Injury
Singh, Raman Deep , Croatt, Anthony J., Ackerman, Allan W., Grande, Joseph P. , Trushina, Eugenia , Salisbury, Jeffrey L., Christensen, Trace , Adams, Christopher M. , Kirkland, James L. , Nath, Karl A. , Tchkonia, Tamara, Nath, Karl A , Adams, Christopher M , Trushina, Eugenia , Tchkonia, Tamar

Mayo Clinic

Kidney360 | August 15, 2022 | Volume: 3 | Issue: 10 | Pages: 1672-1682

10.34067/kid.0004832022 | PMID 36514726 Get It

Key Points In heme protein–induced AKI, mitochondrial functional integrity, as reflected by ATP and NAD + content and NAD + /NADH ratio, is impaired. Mitochondrial quality control is compromised as reflected by impaired biogenesis, exaggerated fission, and marked ultrastructural damage. Modern concepts regarding mitochondria and AKI apply to heme protein–induced AKI, with the possibility of novel therapeutic strategies. Background Mitochondrial injury occurs in and underlies acute kidney injury (AKI) caused by ischemia-reperfusion and other forms of renal injury. However, to date, a comprehensive analysis of this issue has not been undertaken in heme protein–induced AKI (HP-AKI). We examined key aspects of mitochondrial function, expression of proteins relevant to mitochondrial quality control, and mitochondrial ultrastructure in HP-AKI, along with responses to heme in renal proximal tubule epithelial cells. Methods The long-established murine glycerol model of HP-AKI was examined at 8 and 24 hours after HP-AKI. Indices of mitochondrial function (ATP and NAD + ), expression of proteins relevant to mitochondrial dynamics, mitochondrial ultrastructure, and relevant gene/protein expression in heme-exposed renal proximal tubule epithelial cells in vitro were examined. Results ATP and NAD + content and the NAD + /NADH ratio were all reduced in HP-AKI. Expression of relevant proteins indicate that mitochondrial biogenesis (PGC-1 α , NRF1, and TFAM) and fusion (MFN2) were impaired, as was expression of key proteins involved in the integrity of outer and inner mitochondrial membranes (VDAC, Tom20, and Tim23). Conversely, marked upregulation of proteins involved in mitochondrial fission (DRP1) occurred. Ultrastructural studies, including novel 3D imaging, indicate profound changes in mitochondrial structure, including mitochondrial fragmentation, mitochondrial swelling, and misshapen mitochondrial cristae; mitophagy was also observed. Exposure of renal proximal tubule epithelial cells to heme in vitro recapitulated suppression of PGC-1 α (mitochondrial biogenesis) and upregulation of p-DRP1 (mitochondrial fission). Conclusions Modern concepts pertaining to AKI apply to HP-AKI. This study validates the investigation of novel, clinically relevant therapies such as NAD + -boosting agents and mitoprotective agents in HP-AKI.
HF?EF: The Mysterious Relationship Between Heart Failure and Ejection Fraction Continues
Brener, Michael I. , Borlaug, Barry A. , Burkhoff, Daniel , Borlaug, Barry A , Burkhoff, Daniel , Brener, Michael I.

Mayo Clinic

Circulation | August 15, 2022 | Volume: 146 | Issue: 7 | Pages: 519-522

10.1161/circulationaha.122.060540 | PMID 35969653 Get It

High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain
Sandoval, Yader , Apple, Fred S. , Mahler, Simon A. , Jaffe, Allan S. , Jaffe, Allan S. , Body, Richard , Collinson, Paul

Mayo Clinic

Circulation | August 15, 2022 | Volume: 146 | Issue: 7 | Pages: 569-581

10.1161/circulationaha.122.059678 | PMID 35775423 Get It

The 2021 American Heart Association/American College of Cardiology/American Society of Echocardiography/American College of Chest Physicians/Society for Academic Emergency Medicine/Society of Cardiovascular Computed Tomography/Society for Cardiovascular Magnetic Resonance guidelines for the evaluation and diagnosis of acute chest pain make important recommendations that include the recognition of high-sensitivity cardiac troponin (hs-cTn) as the preferred biomarker, endorsement of 99th percentile upper reference limits to define myocardial injury, and the use of clinical decision pathways, as well as acknowledgment of the uniqueness of women and other patient subsets. Details on how to integrate hs-cTn into clinical practice are less extensively addressed. Clinicians should be aware of some of the analytical aspects related to hs-cTn assays regarding the limit of detection and the limit of quantitation and how they are used clinically, especially for the single sample strategy to rule out acute myocardial infarction. Likewise, it is important for clinicians to understand issues related to the derivation of the 99th percentile upper reference limit; the value of sex-specific 99th percentile upper reference limits; how to use changing concentrations (deltas) to facilitate diagnosis and risk stratification of patients with suspected acute coronary syndrome, including the differentiation of acute from chronic myocardial injury; and how to best integrate the use of hs-cTn with clinical decision pathways. With the use of hs-cTn, conditions such as type 2 myocardial infarction become more common, whereas others such as unstable angina become less frequent but still occur. Sections relating to these issues are included.
Adapting integrative cognitive‐affective therapy for adolescents with full and subthreshold bulimia nervosa: A feasibility study
Lebow, Jocelyn , Sim, Leslie , Wonderlich, Stephen A. , Peterson, Carol B. , Lebow, Jocelyn

Mayo Clinic

European Eating Disorders Review | August 15, 2022 | Volume: 31 | Issue: 1 | Pages: 178-187

10.1002/erv.2946 | PMID 35969509 Get It

AbstractBackgroundIntegrative Cognitive Affective Therapy (ICAT) is an empirically supported treatment for bulimia nervosa (BN) in adults. However, it is unclear whether a modified version, Integrative Cognitive Affective Therapy–Adolescent (ICAT‐A) is feasible and beneficial for adolescents. This study evaluated the feasibility of ICAT‐A for adolescents with BN or subthreshold BN.MethodsEight adolescents with BN or subthreshold BN (mean age = 16.1) were enroled in the study. At baseline and end of treatment, adolescents who participated in ICAT‐A completed the Eating Disorder Examination (EDE) and self‐report measures of eating disorder symptoms, depression, anxiety, self‐esteem and functional impairment.ResultsRetention for the intervention (75%) suggests that the majority of participants found the intervention acceptable. Although all treatment completers participated in the clinician‐administered assessment (EDE), compliance with end of treatment self‐report questionnaires was compromised by the COVID‐19 pandemic, which occurred during the treatment course of the majority of the sample. At the end of treatment, all 6 adolescents who completed the ICAT‐A intervention were in full eating disorder remission based on EDE scores, with large effect sizes identified for reductions in EDE global scores (d = 2.71), objective binge episodes (d = 0.91), subjective binge episodes (d = 1.06) and compensatory behaviours (d = 1.72).ConclusionResults suggest that ICAT‐A is a feasible treatment that has promise for the treatment of adolescents with BN. Future studies are necessary to establish the efficacy of ICAT‐A for adolescent BN.